Expanding access to clinical trials is instrumental in achieving equitable cancer care delivery. Clinical trials can be a lifeline for patients with cancer, providing leading-edge care by clinicians dedicated to a specific disease. The oncology community is filled with stories of patients whose lives were improved and/or extended due to participation in a clinical trial. Yet, despite the potential of clinical research to improve outcomes for patients with cancer, enrollment in trials remains low.
The Association of Community Cancer Centers (ACCC) is dedicated to helping the oncology community advance new therapies, expand access to clinical trials, and to close the gap in cancer care delivery by offering the latest education and resources on real-world research, evidence, and clinical trials.
The ACCC Community Oncology Research Institute (ACORI) was launched to address disparities in cancer research and to establish clinical trials as a standard of care for all cancer patients.
The American Society of Clinical Oncology (ASCO) and ACCC have jointly released the Just ASK™ Training Program and Site Self-Assessment resources to help increase the racial and ethnic equity, diversity, and inclusion in cancer clinical trials.
ACCC is committed to ensuring clinical trials are accessible to underserved populations and to closing the gap in cancer research resulting in equitable representation for all patients.
More Community Oncology Research Blog Articles
Adding a clinical trials navigator to this practice team required a
business case that demonstrated return on investment. After a successful
onboarding, this navigator is now the point person to help identify
patients appropriate for clinical trials
and to help busy clinicians with enrollment criteria and trial
Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate—and forward-thinking—solutions to help this population better access clinical trials, including a tool from the Leukemia and Lymphoma Society to help patients identify cancer clinical trials that may be a fit.
More Community Oncology Research Podcasts
An online implicit bias training program that presents the broader context of structural and systemic racism, the role of implicit bias in clinical trial selection, vignettes with real-world examples of implicit bias, and guidance for mitigating disparities in cancer research settings.
The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event that explored practical solutions to strengthen and diversify oncology clinical trials in communities across the country.
(Sep 13-14, 2021)
An expert panel reviews currently available data on cancer care disparities, discusses the needs of disadvantaged populations, and shares practical solutions and methods for implementing bias training. (April 20, 2021)
More On-Demand Webinars
More Community Oncology Research Journal Articles
Diversify Your Cancer Clinical Trials with New Recruitment and Retention Resources
ACCC, Jul 25, 2022
Providing More Equitable Care in Clinical Trials: Oncologists Reflect Over Black History Month
Cancer Network, Feb 28, 2022
Advanced Practice Providers Are Poised to Boost Community Involvement in Clinical Trials
OncLive, July 19, 2021
Association of Community Cancer Centers Launches Institute to Diversify Cancer Clinical Trials
June 2, 2021